WO2002085934A3 - Peptides antibacteriens, les compositions les contenant et leurs utilisations - Google Patents

Peptides antibacteriens, les compositions les contenant et leurs utilisations Download PDF

Info

Publication number
WO2002085934A3
WO2002085934A3 PCT/FR2002/001359 FR0201359W WO02085934A3 WO 2002085934 A3 WO2002085934 A3 WO 2002085934A3 FR 0201359 W FR0201359 W FR 0201359W WO 02085934 A3 WO02085934 A3 WO 02085934A3
Authority
WO
WIPO (PCT)
Prior art keywords
cys
amino acids
peptide radical
peptide
radical
Prior art date
Application number
PCT/FR2002/001359
Other languages
English (en)
Other versions
WO2002085934A2 (fr
Inventor
Jean-Luc Dimarcq
Charles Hetru
Original Assignee
Entomed
Jean-Luc Dimarcq
Charles Hetru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Entomed, Jean-Luc Dimarcq, Charles Hetru filed Critical Entomed
Priority to AU2002257882A priority Critical patent/AU2002257882A1/en
Publication of WO2002085934A2 publication Critical patent/WO2002085934A2/fr
Publication of WO2002085934A3 publication Critical patent/WO2002085934A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/38Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from Aspergillus
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50Isolated enzymes; Isolated proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Agronomy & Crop Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La présente invention a pour objet un peptide antibactérien présentant une structure tridimensionnelle avec une hélice α et un feuillet β antiparallèle reliés par trois ponts disulfures produit par un microorganisme et répondant à la formule générale (I): Xaa-Cys-Xab-Cys-Xac-Cys-Xad-Cys-Xae-Cys-Xaf-Cys-Xag (I), dans laquelle: Xaa est -NH2 ou un reste peptidique comprenant de 1 à 8 acides aminés, Xab est un reste peptidique comprenant de 1 à 12 acides aminés, Xac est un reste peptidique comprenant 3 acides aminés, Xad est un reste peptidique comprenant de 1 à 10 acides aminés, Xae est un reste peptidique comprenant de 1 à 5 acides aminés, Xaf est un reste peptidique comprenant 1 acide aminé, Xag est -OH ou un reste peptidique comprenant 1 ou 2 acides aminés.
PCT/FR2002/001359 2001-04-19 2002-04-19 Peptides antibacteriens, les compositions les contenant et leurs utilisations WO2002085934A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002257882A AU2002257882A1 (en) 2001-04-19 2002-04-19 Antibacterial peptides, compositions containing same and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0105325A FR2823754B1 (fr) 2001-04-19 2001-04-19 Peptides antibacteriens, les compositions les contenant et leurs utilisations
FR01/05325 2001-04-19

Publications (2)

Publication Number Publication Date
WO2002085934A2 WO2002085934A2 (fr) 2002-10-31
WO2002085934A3 true WO2002085934A3 (fr) 2003-11-06

Family

ID=8862488

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2002/001359 WO2002085934A2 (fr) 2001-04-19 2002-04-19 Peptides antibacteriens, les compositions les contenant et leurs utilisations

Country Status (3)

Country Link
AU (1) AU2002257882A1 (fr)
FR (1) FR2823754B1 (fr)
WO (1) WO2002085934A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006053565A2 (fr) 2004-11-19 2006-05-26 Novozymes A/S Polypeptides antimicrobiens et polynucleotides les codant
WO2006072249A1 (fr) * 2005-01-05 2006-07-13 Novozymes A/S Polypeptides a activite antimicrobienne et polynucleotides codant ces polypeptides
NZ561009A (en) 2005-03-16 2009-07-31 Novozymes As Recombinant expression of defensins in filamentous fungi
TW200700076A (en) 2005-03-18 2007-01-01 Novozymes As Polypeptides having antimicrobial activity and polynucleotides encoding same
US20100015663A1 (en) 2007-02-23 2010-01-21 Peter Stephensen Lubeck Method for producing an antifungal peptide in a filamentous fungal host cell
WO2011104284A1 (fr) 2010-02-25 2011-09-01 Novozymes A/S Polypeptides ayant une activité antimicrobienne
AU2018304493B2 (en) 2017-07-17 2022-07-28 Linnane Pharma Ab Peptides with antibiotic potential against Mycobacterium tuberculosis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LOWENBERGER, C. ET AL.: "Insect Immunity: Isolation of Three Novel Inducible Antibacterial Defensins from the Vector Mosquito, Aedes aegypti", INSECT BIOCHEM. MOLEC. BIOL., vol. 25, no. 7, 1995, pages 867 - 873, XP001053123 *

Also Published As

Publication number Publication date
WO2002085934A2 (fr) 2002-10-31
FR2823754B1 (fr) 2004-02-13
FR2823754A1 (fr) 2002-10-25
AU2002257882A1 (en) 2002-11-05

Similar Documents

Publication Publication Date Title
PT1927597T (pt) Péptidos antibacterianos
WO2000053621A3 (fr) Peptides complementaires synthetiques et utilisation ophtalmologique de ceux-ci
EP1644504B8 (fr) Variants du domaine gla du facteur vii ou viia
WO2005009379A3 (fr) Polypeptides pour l'induction d'une reponse immunitaire de protection contre le staphylococcus aureus
NO20081575L (no) Behandling av mikroorganismeinfeksjoner
EP0662516A4 (fr) Nouveau derive d'elafine.
WO2002085934A3 (fr) Peptides antibacteriens, les compositions les contenant et leurs utilisations
AU2002307510A1 (en) Cytokine protein family
AU7791398A (en) Antimicrobial peptides derived from ubiquicidine
ATE481420T1 (de) Il-21-derivate
DE602004028266D1 (de) Angiogene peptide und ihre verwendungen
AU2003264696A1 (en) Cationic linear peptides having antibacterial and/or antifungal properties
ATE353913T1 (de) Neue collectine
AU3674889A (en) Peptide molecules with activity against gram positive microorganisms
DE69418353T2 (de) Cyclische Pentapeptide mit Beta-Turn und Gamma-Turn
EP2143730A3 (fr) Peptides modifiés et leur utilisation pour le traitement des maladies auto-immunes
WO2003048187A3 (fr) Peptides et utilisations de ceux-ci dans des agents therapeutiques contre une infection par le virus vih
WO2004042043A3 (fr) Structures cristallines de 3-epimerases bacteriennes de ribulose-phosphate
WO2022136442A3 (fr) Compositions comprenant des cyclotides et d'autres peptides insecticides et utilisations associées
EP1295943A4 (fr) Polypeptides capables le pouvoir de stimuler les neutrophiles
WO2003066849A3 (fr) Nouveaux polypeptides purifies issus de staphylococcus aureus
WO2003027274A3 (fr) Nouveau polypeptide purifie tire de pseudomonas aeruginosa
WO2004058811A3 (fr) Structures cristallines des polypeptides yhhf
WO2004058812A3 (fr) Polypeptides purifies issus de enterococcus faecalis
WO2004042044A3 (fr) Structures cristallines de kinases bacteriennes de guanylate

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP